Hm Payson & CO Shockwave Medical, Inc. Transaction History

Hm Payson & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$115.91 - $214.48 $115 - $214	1 New	1 $0
Q1 2022 May 12, 2022	SELL	$127.96 - $207.36 $54,894 - $88,957	-429 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$165.13 - $241.83 $70,840 - $103,745	429 New	429 $77,000
Q2 2021 Aug 17, 2021	SELL	$131.45 - $201.49 $91,752 - $140,640	-698 Closed	0 $0
Q4 2020 Mar 10, 2021	SELL	$67.44 - $103.72 $11,869 - $18,254	-176 Reduced 20.14%	698 $72,000
Q3 2020 Dec 21, 2020	BUY	$42.79 - $75.8 $37,398 - $66,249	874 New	874 $66,000

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

Stay updated on Hm Payson & CO with notifications on news.